Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hypertriglyceridemia 2 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
hypertriglyceridemia 4572 modify cardiometabolic biomarkers. For example, data suggest that n-3PUFA may improve postprandial hypertriglyceridemia , hyperglycaemia, insulin secretion ability and endothelial function in patients with impaired glucose
hypertriglyceridemia 22302 T2DM is associated with dyslipidaemia (4). n-3PUFA intake has long been indicated in the treatment of hypertriglyceridemia [[30], [31]], promoting reductions in hepatic TG synthesis and accelerating triglyceride clearance [[32]–[34]].

You must be authorized to submit a review.